Dolutegravir Antiretroviral Strategy to Promote Improvement and Reduce Drug Exposure
Clinical trial NCT02263326 · COMPLETED
Trial details
- NCT number
- NCT02263326
- Sponsor
- Babafemi Taiwo
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2017-07-01
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.